Health Care Policy

Antibiotic resistance has been brought by their overuse and misuse resulting to ineffectiveness. It is more advisable to the nurses to embrace evidence-based treatment rather than just giving the treatment to the patient as a routine or they need one (Health Affairs, 2015). This is because treatment becomes more complex as the bacteria causing infection become more resistant worsening the initial condition. With time the MRSA have become ineffective and their continued administration causing about 19,000 deaths yearly. This means that despite the much-needed want of the antibiotics there is arises a need of developing other new antibiotics that will work together in order to increase their effectiveness (Health Affairs, 2015).

In order to facilitate quality treatment to the patients, it is useful to implement the policy of GAIN. This is because there will be a comprehensive national plan of finance resulting to accountability and strengthened surveillance and increased laboratory capacity (Health Affairs, 2015). The policy will also prevent and control preventions and foster more research in the antibiotics field. This is relevant to me because I will be able to take fewer and stronger antibiotics that are more effective in my toe infection compared to the current situation.

This policy will cater for the life-threatening infections without the generic competition. This act will also be able to increase profits that will be generated from the sale of the new advanced antibiotics encouraging more development of the antibiotics (Kahn, 2016). It will also reduce the number of antibiotics take in daily by the patients thus reducing the effects it has on their body after a long time of the antibiotics administration. It is, therefore, important to reconsider the policy due to its numerous advantages (Kahn, 2016).

 

Reference

Health Affairs. (2015, May 21). Antibiotic Resistance. Retrieved from http://www.healthaffairs.org/healthpolicybriefs/brief.php?brief_id=138

Kahn, L. H. (2016). One Health and the politics of antimicrobial resistance. Baltimore : Johns Hopkins University Press